Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

RxSight (RXST) Profit After Tax (2020 - 2025)

RxSight's Profit After Tax history spans 6 years, with the latest figure at -$9.2 million for Q4 2025.

  • For Q4 2025, Profit After Tax fell 54.13% year-over-year to -$9.2 million; the TTM value through Dec 2025 reached -$38.9 million, down 41.85%, while the annual FY2025 figure was -$38.9 million, 41.85% down from the prior year.
  • Profit After Tax reached -$9.2 million in Q4 2025 per RXST's latest filing, up from -$9.8 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$5.9 million in Q4 2024 to a low of -$17.6 million in Q1 2022.
  • Average Profit After Tax over 5 years is -$11.5 million, with a median of -$12.1 million recorded in 2023.
  • Peak YoY movement for Profit After Tax: tumbled 159.84% in 2021, then soared 55.96% in 2024.
  • A 5-year view of Profit After Tax shows it stood at -$15.7 million in 2021, then grew by 0.79% to -$15.6 million in 2022, then skyrocketed by 41.21% to -$9.2 million in 2023, then soared by 35.29% to -$5.9 million in 2024, then tumbled by 54.13% to -$9.2 million in 2025.
  • Per Business Quant, the three most recent readings for RXST's Profit After Tax are -$9.2 million (Q4 2025), -$9.8 million (Q3 2025), and -$11.8 million (Q2 2025).